These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32504831)

  • 1. Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation.
    Carli M; Donnini S; Pellegrini C; Coppi E; Bocci G
    Pharmacol Res; 2020 Sep; 159():104938. PubMed ID: 32504831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin-1A receptor dependent modulation of pain and reward for improving therapy of chronic pain.
    Haleem DJ
    Pharmacol Res; 2018 Aug; 134():212-219. PubMed ID: 29969666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schedules of Controlled Substances: Removal of Naldemedine From Control. Final rule.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Sep; 82(188):45436-8. PubMed ID: 28990740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (3R,4R,4aS,7aR,12bS)-3-Cyclo-propyl-methyl-4a,9-dihy-droxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octa-hydro-1H-4,12-methano-benzofuro[3,2-e]isoquinolin-3-ium bromide.
    Chen X; Zong Z; Du Y; Li J; Sun M
    Acta Crystallogr Sect E Struct Rep Online; 2012 Feb; 68(Pt 2):o405-6. PubMed ID: 22347024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (3S,4R,4aS,7aR,12bS)-3-Cyclo-propyl-meth-yl-4a,9-dihy-droxy-3-methyl-7-oxo-2,3,4,4a,5,6,7,7a-octa-hydro-1H-4,12-methano-1-benzofuro[3,2-e]isoquinolin-3-ium 2,2,2-trifluoro-acetate methanol solvate.
    Cai X; Zhou X; Zheng Z; Zhong W; Li S
    Acta Crystallogr Sect E Struct Rep Online; 2010 Oct; 66(Pt 11):o2868. PubMed ID: 21589050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New solvates of the drug naltrexone: protonation, conformation and interplay of synthons.
    Gonçalves KO; Ribeiro L; Oliveira CMA; Carvalho JF; Martins FT
    Acta Crystallogr C Struct Chem; 2018 Mar; 74(Pt 3):274-282. PubMed ID: 29504554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P
    Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders.
    Rorick-Kehn LM; Witkin JM; Statnick MA; Eberle EL; McKinzie JH; Kahl SD; Forster BM; Wong CJ; Li X; Crile RS; Shaw DB; Sahr AE; Adams BL; Quimby SJ; Diaz N; Jimenez A; Pedregal C; Mitch CH; Knopp KL; Anderson WH; Cramer JW; McKinzie DL
    Neuropharmacology; 2014 Feb; 77():131-44. PubMed ID: 24071566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hexahydro-1H-1-pyrindines from acid rearrangement of 9-alkylidene-5-(m-methoxyphenyl)-2-methylmorphans. A new structural type of narcotic antagonists.
    Awaya H; May EL; Aceto MD; Harris LS; Silverton JV; Rice KC; Mattson MV; Jacobson AE
    J Med Chem; 1987 May; 30(5):947-50. PubMed ID: 3033248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a deuterated 6-AmHap internal standard for the determination of hapten density in a heroin vaccine drug product.
    Makarova M; Barrientos RC; Torres OB; Matyas GR; Jacobson AE; Sulima A; Rice KC
    J Labelled Comp Radiopharm; 2020 Nov; 63(13):564-571. PubMed ID: 32876947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioids and Cancer Mortality.
    Amaram-Davila J; Davis M; Reddy A
    Curr Treat Options Oncol; 2020 Feb; 21(3):22. PubMed ID: 32095929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid Receptors.
    Stein C
    Annu Rev Med; 2016; 67():433-51. PubMed ID: 26332001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.
    Brinkman D; Wang JH; Redmond HP
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1169-1178. PubMed ID: 30232510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Opioid Receptors in Cancer.
    Bhoir S; Uhelski M; Guerra-Londono JJ; Cata JP
    Adv Biol (Weinh); 2023 Jul; 7(7):e2300102. PubMed ID: 37132160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analgesic effects of systemic fentanyl on cancer pain are mediated by not only central but also peripheral opioid receptors in mice.
    Shinohara A; Andoh T; Saiki I; Kuraishi Y
    Eur J Pharmacol; 2018 Aug; 833():275-282. PubMed ID: 29886241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights in opioid agonists and antagonists.
    Lauretti GR
    Expert Rev Neurother; 2006 Apr; 6(4):613-22. PubMed ID: 16623659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of opioid receptor blockade determines biotherapeutic response.
    McLaughlin PJ; Zagon IS
    Biochem Pharmacol; 2015 Oct; 97(3):236-46. PubMed ID: 26119823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exposure to saccharin reduces morphine analgesia in the the rat: evidence for involvement of N-methyl-D-aspartate and peripheral opioid receptors.
    McNally GP; Westbrook RF
    Psychopharmacology (Berl); 2000 Mar; 149(1):56-62. PubMed ID: 10789883
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.